Skip to main content

Table 3 Meta-analysis of the XPC polymorphisms and gastric cancer risk

From: Current evidences on XPC polymorphisms and gastric cancer susceptibility: a meta-analysis

Comparison

Population

No. of studies

Test of association

Mode

Test of heterogeneity

   

OR

95% CI

P Value

 

χ 2

P Q Value

I 2

Lys939Gln

         

Gln/Gln vs. Lys/lys

Overall

5

1.123

0.881-1.431

0.349

F

2.69

0.612

0.0

 

Caucasian

2

1.016

0.490-2.109

0.965

F

2.31

0.128

46.8

 

Asian

3

1.140

0.857-1.516

0.368

F

0.34

0.843

0.0

 

PB

2

1.260

0.877-1.810

0.212

F

0.24

0.623

0.0

 

HB

3

1.026

0.741-1.420

0.879

F

1.76

0.414

0.0

 

High quality

3

1.179

0.860-1.616

0.308

F

0.75

0.686

0.0

 

Low quality

2

1.048

0.718-1.530

0.807

F

1.71

0.191

41.6

Gln/Lys vs. Lys/lys

Overall

5

1.083

0.917-1.277

0.347

F

1.21

0.876

0.0

 

Caucasian

2

0.993

0.689-1.432

0.972

F

0.87

0.352

0.0

 

Asian

3

1.107

0.919-1.332

0.284

F

0.08

0.962

0.0

 

PB

2

1.026

0.795-1.324

0.846

F

0.64

0.424

0.0

 

HB

3

1.126

0.906-1.400

0.285

F

0.27

0.872

0.0

 

High quality

3

1.062

0.855-1.319

0.587

F

0.90

0.639

0.0

 

Low quality

2

1.112

0.861-1.437

0.417

F

0.24

0.628

0.0

Gln/Gln + Gln/Lys vs. Lys/lys

Overall

5

1.092

0.933-1.277

0.273

F

0.24

0.994

0.0

 

Caucasian

2

1.015

0.720-1.430

0.933

F

0.01

0.906

0.0

 

Asian

3

1.113

0.933-1.327

0.235

F

0.00

0.998

0.0

 

PB

2

1.076

0.846-1.369

0.551

F

0.18

0.667

0.0

 

HB

3

1.103

0.897-1.356

0.351

F

0.03

0.986

0.0

 

High quality

3

1.087

0.886-1.333

0.424

F

0.21

0.900

0.0

 

Low quality

2

1.098

0.860-1.401

0.453

F

0.02

0.881

0.0

Gln/Gln vs. Gln/Lys + Lys/lys

Overall

5

1.046

0.838-1.307

0.691

F

6.57

0.160

39.2

 

Caucasian

2

0.921

0.344-2.468

0.870

F

5.98

0.114

43.3

 

Asian

3

1.083

0.829-1.417

0.558

F

0.47

0.791

0.0

 

PB

2

1.253

0.896-1.751

0.187

F

0.77

0.381

0.0

 

HB

3

0.914

0.680-1.229

0.552

F

3.90

0.142

48.8

 

High quality

3

1.157

0.862-1.553

0.331

F

1.66

0.435

0.0

 

Low quality

2

0.828

0.400-1.712

0.610

F

3.90

0.148

44.3

Ala499Val

         

Val/Val vs. Ala/Ala

Asian

3

0.861

0.632-1.172

0.341

F

0.57

0.754

0.0

Val/Ala vs. Ala/Ala

Asian

3

0.815

0.611-1.089

0.167

F

4.72

0.194

37.6

Val/Val + Val/Ala vs. Ala/Ala

Asian

3

0.823

0.630-1.076

0.155

F

4.49

0.106

35.5

Val/Val vs. Val/Ala + Ala/Ala

Asian

3

0.947

0.703-1.274

0.717

F

0.04

0.981

0.0

PAT−/+

         

+/+vs. −/−

Overall

2

1.035

0.763-1.404

0.825

F

0.12

0.726

0.0

+/− vs. −/−

Overall

2

0.855

0.681-1.073

0.176

F

0.00

0.975

0.0

(+/+) + (+/−) vs. (−/−)

Overall

2

0.896

0.724-1.111

0.317

F

0.05

0.830

0.0

(+/+) vs. (+/−) + (−/−)

Overall

2

1.141

0.871-1.495

0.338

F

0.20

0.652

0.0

  1. OR, odds ratio; CI, confidence intervals; R, random effects model; F, fixed effects model; PB, Population–based; HB, Hospital–based.